JP
John Pribis
Founder of Solu Therapeutics
JP
John Pribis
Founder of Solu Therapeutics
Brookline, Massachusetts
Overview
Work Experience
Co-founder, Head of Business Strategy
2024 - Current
Co-founder and Head of BD, Strategy, and Operations
2023 - 2024
Founding VP of Strategy and Operations
2022 - 2023
Senior Associate
2021 - 2023
Co-founder, VP Strategy & Operations
2021 - 2022
Co-founder, FL77, Inc (Apriori Bio)
2020 - 2021
Associate
2019 - 2021
Flagship Venture Fellow
2019 - 2019
Graduate Student
2013 - 2019
Mechanisms of Antibiotic Resistance and Bacterial Evolvability
Director of Tri-Institutional Drug Discovery Program & Research Fellow
2008 - 2013
Team leader of a tri-institutional drug discovery program that led to the discovery of several drugs to treat sterile inflammation. Inflammation, traumatic injury, and susceptibility to infection after injury.